Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06219018
PHASE1/PHASE2

Effect of Honey For CIN II

Sponsor: Zuyderland Medisch Centrum

View on ClinicalTrials.gov

Summary

The following hypothesis is tested: Medical grade honey in CIN II causes a higher clearance of the hr-HPV virus and an increase in the normalization of CIN II lesions compared to expectant management.

Official title: The Effect of Medical Grade Honey (L-Mesitran) for Cervical Intraepithelial Neoplasia-II

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2024-12-30

Completion Date

2027-12-01

Last Updated

2025-06-18

Healthy Volunteers

Yes

Interventions

DRUG

Medical grade honey formulation (MGH) (L-Mesitran®)

Daily application of 5 grams (with applicator) for the first 3 months, followed by weekly application of 5 grams for the following 3 months.

Locations (2)

Zuyderland MC

Heerlen, Limburg, Netherlands

Maastricht University Medical Centre+

Maastricht, Limburg, Netherlands